Page 268 - ASHG 2013 Program Guide

POSTER SESSIONS
  255
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
3472
T LOH analysis of the
ING3
and
ING5
genes in
breast cancer.
G. Nas, E. Gunduz, M. Acar, E. Uctepe,
M. Bozer, C. Dener, S. Yenidunya, M. Gunduz.
3473
F Characterization of molecular alterations in
urologic cancers.
M. L. Nickerson, K. M. Im, S. Turan,
T. Andresson, L. E. Moore, M. Dean.
3474
W Exome sequencing identifies putative drivers
of progression of transient myeloproliferative disorder
to AMKL in infants with Down syndrome.
S. I. Nikolaev,
F. Santoni, A. Vannier, E. Falconnet, E. Giarin, G. Basso,
A. Hoischen, J. A. Veltman, J. Groet, D. Nizetic,
S. E. Antonarakis.
3475
T Characterization of somatic alterations in the
novel tumor suppressor
DEAR1
using ultra-deep
targeted next-generation sequencing.
J. Reuther,
N. Chen, A. Sahin, S. Lott, A. Killary.
3476
F Individualized analysis of somatic mutations
and CNV from exomes obtained from breast cancer
core needle biopsies in women with newly diagnosed
locally advanced breast cancer.
H. Sicotte, S. Hart, J.
P. Sinwell, S. Baheti, P. T. Vedell, K. R. Kalari, X. Tang, K.
J. Thompson, D. W. Mahoney, P. Barman, J. M. Evans, C.
Wang, Y. W. Asmann, J. P. A. Kocher, T. J. Dockter, K. N.
Jones, A. L. Conners, A. M. Moyer, D. W. Visscher, V. J.
Suman, J. Eckel Passow, R. Weinshilboum, L. Wang, J. C.
Boughey, M. P. Goetz.
3477
W Subclonal evolution and genomic drivers of
relapse in childhood acute lymphoblastic leukemia.
J.-F. Spinella, R. Vidal, J. Healy, V. Saillour, C. Richer,
P. Cassart, M. Ouimet, S. Busche, B. Ge, T. Pastinen,
D. Sinnett.
3478
T Ultra-high quality sequencing assay for
comprehensive genetic panel analysis of rare
tumor-derived circulating cell-free DNA.
A. Talasaz,
D. Sebisanovic, G. Mei, L. Siew, H. Eltoukhy.
3479
F Next-generation sequencing of
BRCA1
and
BRCA2
in Bulgarian breast cancer patients and
controls.
D. I. Toncheva, L. Balabanski, G. Antov,
I. Dimova, S. Ivanov, M. Nacheva, I. Gavrilov, D. Nesheva,
B. Rukova, S. Hadzhidekova, M. Malinov.
3480
W Recurrent somatic mutations in loss of
heterozygosity regions of hepatocellular carcinoma.
S. Tsai, Y. Lin.
3481
T Importance of genetic analysis in the
prediction of retinoblastoma in South Indian patients.
A. Vanniarajan, G. Namrata, K. Usha, R. S. Akram,
K. Thirumalairaj, I. Jeyaram, R. Santhi, R. Kim, V. R.
Muthukkaruppan.
3482
F Exome sequencing identifies ecurrent somatic
mutations in
EIF1AX
and
SF3B1
in uveal melanoma
with disomy 3.
M. Zeschnigk, M. Martin, L. Ma
b
höfer,
P. Temming, S. Rahmann, C. Metz, N. Bornfeld, J. van de
Nes, L. Klein-Hitpass, A. G. Hinnebusch, B. Horsthemke,
D. R. Lohmann.
3461
F Somatic mutation profiles of non-synd omic
early-onset colorectal cancer.
N. Jinawath,
T. Pongrujikorn, S. Ngernna, C. Songpattanasilp, J.-S. Su,
A. Jinawath, A. Tunteeratam, B. Suktitipat.
3462
W Comprehensive molecular analysis of basal
breast cancer treated with neoadjuvant paclitaxel.
K.
R. Kalari, X. Tang, K. J. Thompson, P. T. Vedell, H. Sicotte,
S. N. Hart, A. Moyer, D. Visscher, A. A. Nair, J. P. Sinnwell,
D. W. Mahoney, P. Barman, T. J. Dockter, K.N. Jones, A. L.
Conners, V. J. Suman, J. E. Eckel-Passow, C. G. Schultz,
J. P. Kocher, E. D. Wieben, R. M. Weinshilboum, L. Wang,
J. C. Boughey, M. P. Goetz.
3463
T Next-generation sequencing of osteosarcoma
identifies the PI3K/mTOR pathway as a unifying
vulnerability to be exploited for targeted therapy.
A. Kiezun, K. Janeway, P. Tonzi, J. Mora, S. Aguiar,
G. Mercado, J. Melendez, L. Garraway, C. Rodriguez-
Galindo, S. Orkin, T. Golub, G. Getz, J. A. Yunes.
3464
F RNA-seq revealed alternative splicing and
fusion transcripts in non-small cell lung cancer.
W. Kim,
S. Park, M. Cheon.
3465
W Exome sequencing of mammospheres and
primary tumors indicates dynamic transitions between
stem-like and differentiated states in breast cancer.
D. Klevebring, G. Rosin, R. Ma, J. Lindberg, K. Czene,
J. Kere, I. Fredriksson, J. Bergh, J. Hartman.
3466
T Genomic alterations during disease evolution
in CML patients displaying an isochromosome
17
q.
N. Larsson, H. Liljebjorn, M. Rissler, C. Högberg,
J. Richter, T. Fioretos.
3467
F Whole exome sequencing identifies di ferent sets
of gene mutations in various subtypes of early-onset
breast cancers.
C. Y. Lee, W. H. Kuo, C. H. Lin, Y. S. Lu,
H. I. Yang, K. Y. Lo, C. K. Liu, C. H. Chang, C. N. Hsiung, N.
Leng, K. Nobuta, C. D. Haudenschild, C. H. Chen, J. Y. Wu,
K. P. Chiu, A. L. Cheng, K. J. Chang, C. Y. Shen, C. J. Chen.
3468
W Exome sequencing of cell-free plasma DNA in
prostate cancer patients.
J. Lindberg, M. Neiman, D.
Klevebring, P. Wiklund, L. Egevad, H. Grönberg.
3469
T Mutational enrichment of cancer-related gene
sets in 11 aggressive prostate cancers.
K. J. Lindquist,
R. Kazma, T. J. Hoffmann, B. A. Rybicki, A. Levin,
P. L. Paris, J. S. Witte.
3470
F Retrospective analysis of genomic and
transcriptional changes in a case of Ewing’s
sarcoma tumor progression determined by whole
transcriptome and exome semiconductor-based
sequencing.
G. Meredith, Y. Sun, N. S. Hernandez,
M. Taylor, B. Sanderson, K. Giorda, T. Woodburn, G. Bee,
J. Bishop, S. Ghosh, P. Kapranov, J. Buckley, K. Bramlett,
C. P. Reynolds, T. Triche.
3471
W Immunohistochemical analysis of uterine
leiomyomas, histopathological uterine leiomyoma
subtypes, and uterine leiomyosarcomas.
N. Mäkinen,
K. Kämpjärvi, R. Bützow, P. Vahteristo.